SCHEMBL1207010

SCHEMBL1207010

O=CN1[CH]COCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1208291 0.68
SCHEMBL4838486 0.67
SCHEMBL28324194 0.65
SCHEMBL3276308 0.62
SCHEMBL894995 0.62
SCHEMBL27993891 0.62
SCHEMBL28053744 0.62
SCHEMBL37780 0.62
SCHEMBL492362 0.62
SCHEMBL27994147 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020026053-A1 Novel 3-(substituted) -2- indolinones compounds and use thereof as inhibitors of protein kinase activity TANG PENG CHO (US) 2002-02-28 US claimed
US-20010007033-A1 Novel 3-(substituted)-2-indolinones compounds and use thereof as inhibitors of protein kinase activity SUGEN, INC. 2001-07-05 US claimed
US-20110044938-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES NYCOMED GMBH (DE) 2011-02-24 US disclosed
EP-2051974-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES 4SC AG (DE) 2009-04-29 EP disclosed
WO-2008020045-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES 4SC AG (DE) 2008-02-21 WO disclosed
US-6506763-B2 Useful in prevention and treatment of protein kinase related disorders such as cancer SUGEN, INC. 2003-01-14 US disclosed
US-20020026053-A1 Novel 3-(substituted) -2- indolinones compounds and use thereof as inhibitors of protein kinase activity TANG PENG CHO (US) 2002-02-28 US disclosed
US-20010007033-A1 Novel 3-(substituted)-2-indolinones compounds and use thereof as inhibitors of protein kinase activity SUGEN, INC. 2001-07-05 US disclosed
US-6133305-A PREVENTION AND TREATMENT OF PROTEIN KINASE RELATED DISORDERS SUCH AS CANCER SUGEN, INC. (US) 2000-10-17 US disclosed